Ensuring the involvement of children in the evaluation of new tuberculosis treatment regimens.

Ensuring the involvement of children in the evaluation of new tuberculosis treatment regimens.

We are on the threshold of revolutionary improvements in the treatment of tuberculosis. Within five to ten years, it is likely that highly effective three-month regimens will be available to treat both active and latent drug-susceptible tuberculosis. New drug classes that have the potential to drama...

Bibliografske podrobnosti
Main Authors:	Burman, W, Cotton, M, Gibb, D, Walker, A, Vernon, A, Donald, P
Format:	Journal article
Jezik:	English
Izdano:	Public Library of Science 2008

Podobne knjige/članki

Ensuring the involvement of children in the evaluation of new tuberculosis treatment regimens.
od: William J Burman, et al.
Izdano: (2008-08-01)

Tuberculosis: Development of New Drugs and Treatment Regimens
od: Soedarsono Soedarsono
Izdano: (2021-01-01)

New regimens and new medications in the treatment of tuberculosis: keeping step?
od: Ruzanov D.Y., et al.
Izdano: (2021-04-01)

Safety of new tuberculosis treatment regimens and compliance with these regimens according to data from the Republic of Kazakhstan
od: Zh. T. Zhandauletova, et al.
Izdano: (2023-03-01)

Toxicity of treatment regimens for drugresistant tuberculosis.
od: G. N. Mozhokina, et al.
Izdano: (2022-03-01)

Bedaquiline in the treatment regimen of multidrugresistant tuberculosis (clinical observation)
od: V. A. Aksenova, et al.
Izdano: (2020-11-01)

ECONOMIC FEASIBILITY OF NEW CHEMOTHERAPY REGIMENS FOR TREATMENT OF TUBERCULOSIS PATIENTS WITH EXTENSIVE DRUG RESISTANCE
od: I. A. Vasilyeva, et al.
Izdano: (2018-07-01)

Optimizing tuberculosis treatment efficacy: Comparing the standard regimen with Moxifloxacin-containing regimens.
od: Maral Budak, et al.
Izdano: (2023-06-01)

New drugs and perspectives for new anti-tuberculosis regimens
od: S. Tiberi, et al.
Izdano: (2018-03-01)

Recent advancements in tuberculosis (TB) treatment regimens
od: Shyamala Ravikoti, et al.
Izdano: (2025-02-01)

Optimization of dosing regimens of isoniazid and rifampicin in children with tuberculosis in India
od: Aruldhas, B, et al.
Izdano: (2018)

Biotransformation enzymes for xenobiotics and personalization of treatment regimens for tuberculosis patients
od: G. N. Mozhokina, et al.
Izdano: (2016-04-01)

Efficacy and safety of regimen containing bedaquiline in children with drug-resistant tuberculosis
od: V. A. Aksenova, et al.
Izdano: (2021-10-01)

Non-Injection Chemotherapy Regimens for Drug Resistant Tuberculosis in Children and Adolescents
od: V. A. Aksenova, et al.
Izdano: (2023-12-01)

The pipeline of new molecules and regimens against drug-resistant tuberculosis
od: Todd A. Black, et al.
Izdano: (2021-12-01)

ADVERSE SIDE EFFECTS OF TUBERCULOSIS ETIOTROPIC TREATMENT REGIMENS CONTAINING THE NEW ANTI-TUBERCULOSIS DRUG OF SQ109
od: S. E. Borisov
Izdano: (2018-08-01)

New anti-tuberculosis drugs and regimens: 2015 update
od: Lia D'Ambrosio, et al.
Izdano: (2015-05-01)

Multidrug-resistant tuberculosis treatment with linezolid-containing regimen
od: Maham Farshidpour, et al.
Izdano: (2013-01-01)

Cost-effectiveness of adding bedaquiline to drug regimens for the treatment of multidrug-resistant tuberculosis in the UK.
od: Lara J Wolfson, et al.
Izdano: (2015-01-01)

Contemporary approaches to the search for active drugs and chemotherapy regimens for tuberculosis treatment
od: T. K. Lugovkinа, et al.
Izdano: (2020-07-01)

ENSURING PERSONNEL INVOLVEMENT IN COMPANIES’ SUSTAINABLE DEVELOPMENT
od: A. V. Kolobov, et al.
Izdano: (2021-01-01)

Advancing the development of new tuberculosis treatment regimens: The essential role of translational and clinical pharmacology and microbiology.
od: Kelly E Dooley, et al.
Izdano: (2019-07-01)

Safety of longer linezolid regimen in children with drug-resistant tuberculosis and extensive tuberculosis in Southwest China
od: ZhenZhen Zhang, et al.
Izdano: (2020-06-01)

An optimized background regimen design to evaluate the contribution of levofloxacin to multidrug-resistant tuberculosis treatment regimens: study protocol for a randomized controlled trial
od: Tara C. Bouton, et al.
Izdano: (2017-11-01)

Time to culture conversion and regimen composition in multidrug-resistant tuberculosis treatment.
od: Dylan B Tierney, et al.
Izdano: (2014-01-01)

Safety of treatment regimens in multiple drug resistant tuberculosis patients compiled as per the new WHO recommendations as of 2019
od: D. A. Ivanova, et al.
Izdano: (2020-02-01)

Preclinical Evaluations To Identify Optimal Linezolid Regimens for Tuberculosis Therapy
od: Ashley N. Brown, et al.
Izdano: (2015-12-01)

Estimated Costs of 4-Month Pulmonary Tuberculosis Treatment Regimen, United States
od: Carla A. Winston, et al.
Izdano: (2023-10-01)

Short-Course Chemotherapy Regimens for Treatment of Multiple and Pre-Extensive Drug Resistant Tuberculosis in Combination with Surgery in Older Children and Adolescents
od: E. S. Ovsyankina, et al.
Izdano: (2024-12-01)

INVOLVEMENT OF DIFFERENT STAKEHOLDER GROUPS IN ENSURING CHILDREN’S DENTAL PUBLIC HEALTH: ANALYSIS AND PERSPECTIVES
od: Lilia V. Kriachkova, et al.
Izdano: (2024-03-01)

Clinical Efficacy and Safety of Clofazimine in Treatment Regimens for Drug Resistant Tuberculosis (Meta-Analysis)
od: A. I. Gayda, et al.
Izdano: (2024-05-01)

Evaluation of Safety of 9- and 6-Month Treatment Regimens in Patients with Rifampicin-Resistant Tuberculosis in the Republic of Belarus
od: N. V. Yatskevich, et al.
Izdano: (2024-03-01)

Cost-effectiveness of short, oral treatment regimens for rifampicin resistant tuberculosis.
od: Sedona Sweeney, et al.
Izdano: (2022-01-01)

Cost-effectiveness of short, oral treatment regimens for rifampicin resistant tuberculosis
od: Sedona Sweeney, et al.
Izdano: (2022-01-01)

Outcomes associated with standardized treatment regimens for extensively drug-resistant tuberculosis
od: Anivita Aggarwal, et al.
Izdano: (2020-01-01)

Prioritising attributes for tuberculosis preventive treatment regimens: a modelling analysis
od: Juan F. Vesga, et al.
Izdano: (2022-05-01)

Adherence and Associated Factors of Treatment Regimen in Drug-Susceptible Tuberculosis Patients
od: Sungho Bea, et al.
Izdano: (2021-03-01)

Efficacy of standard chemotherapy regimens in children and adolescents suffering from respiratory tuberculosis
od: E. F. Luginova, et al.
Izdano: (2020-12-01)

Poor response to tuberculosis treatment with regimens without rifampicin in immunosuppressed AIDS patients
od: M.M. O'Donnel, et al.

Poor response to tuberculosis treatment with regimens without rifampicin in immunosuppressed AIDS patients
od: O'Donnel M.M., et al.
Izdano: (2002-01-01)